🇺🇸 FDA
Company

Tenaya

Tenaya Therapeutics

TNYA biotech USA

Quick answer

Tenaya is a biotech company (TNYA) headquartered in SOUTH SAN FRANCISCO, CA, USA with 2 tracked pipeline programs.

Pipeline (2)

project

TN-201

Hypertrophic Cardiomyopathy

Phase 2 · gene_therapy · active

1 trials project

TN-401

Arrhythmogenic Right Ventricular Cardiomyopathy

Phase 1 · gene_therapy · active

1 trials

Patents (8)

patent

US 12312345

Fluoroalkyl-oxadiazoles and uses thereof

Expires Mon May 22 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12201617

HDAC6 inhibitors for treatment of metabolic disease and HFpEF

Expires Mon Jan 16 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12168778

Cardiac cell reprogramming with myocardin and ASCL1

Expires Mon Dec 12 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12151001

Optimized expression cassettes for gene therapy

Expires Mon Nov 21 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 12104165

Adeno-associated virus with engineered capsid

Expires Mon Sep 26 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11926622

Fluoroalkyl-oxadiazoles and uses thereof

Expires Mon Mar 07 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11913012

Cardiac cell reprogramming with myocardin and ASCL1

Expires Mon Feb 22 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

 patent

US 11781156

Plakophillin-2 gene therapy methods and compositions

Expires Mon Oct 05 2043 00:00:00 GMT+0000 (Coordinated Universal Time)